Login     Register  
    Home  |   Your Profile  |   Search  |   About Us  |   Pricing  |   Disclaimer
UBioMed - Biomedical Research from Universities and Research Institutes. MMS Holdings Inc. is an ISO 9001:2000 Certified organization located in Canton, Michigan. We provide clinical development support, medical writing, clinical programming, biostatistics and regulatory affairs services to the pharmaceutical, biotechnology and medical device industry. Quality and commitment are the hallmarks of our success and every project we complete reflects our core values and principles.
Site Search:
    Home Research News Biopharma Investor Reports Store Directory Events Advertising Career/ Training Industry News Search Tools
 UBioMed: Pharma   Show all: UBioMed: Pharma
DUAL-DRUG THERAPY TARGETS ONE COLON CANCER GENE
Johns Hopkins University   15 Aug 2005
New Stroke-Prevention Drug Unlikely to be Cost-Effective Except in Patients at High Risk of Bleeding
Washington University in St. Louis   8 Feb 2005
SILDENAFIL EFFECTIVELY TREATS ENLARGED HEARTS, MOUSE STUDY SHOWS
Johns Hopkins University   23 Jan 2005
KGK Synergize Ensures Suppliers Deliver the Highest Quality Ingredients for their Nutraceutical Product Pipeline
London Economic Development Corp   16 Dec 2004
STUDY SHOWS HIGH-DOSE VITAMIN E SUPPLEMENTS MAY INCREASE RISK OF DYING
Johns Hopkins University   10 Nov 2004
HOW A HORMONE REGULATES IRON
University of Utah   28 Oct 2004
ANTIPSYCHOTIC DRUGS LINKED TO INSULIN RESISTANCE IN CHILDREN Metabolic monitoring may be indicated for patients
Johns Hopkins University   20 Oct 2004
New Technique Helps Scientists Reveal Interactions Between Genes and Drugs
Washington University in St. Louis   2 Aug 2004
DOCETAXEL EXTENDS LIFE IN ADVANCED PROSTATE CANCER PATIENTS
Johns Hopkins University   7 Jun 2004
AtheroChem, Inc. to focus on treatments for cholesterol-related heart disease
PARTEQ   20 Apr 2004
Linezolid is Superior Treatment for Drug-Resistant Pneumonia
Washington University in St. Louis   2 Mar 2004
Findings Could Aid Efforts to Harness Nature for Making Drugs
Purdue University   27 Jan 2004
GB Therapeutics receives FDA approval to begin clinical trials of Alzheimer's candidate
PARTEQ   7 Jan 2004
Protein That Predicts Tamoxifen Resistance is Identified
Duke University   4 Dec 2003
New Drug Proves Helpful for Treating Long-Term Insomnia
Duke University   20 Oct 2003
For those who take painkillers regularly, a heartburn pill a day may keep ulcers away
University of Michigan   17 Oct 2003
New Insight into Heart Failure Suggests Novel Drug Target
Duke University   5 Oct 2003
Duke to Lead First Comparative Trial of Hepatitis C Therapies
Duke University   24 Sep 2003

Using the Site  Privacy & Security Statement
Career  Advertise with us  Directory Guide 
  CanBiotech Newsletters

  © 2000-2007 CanBiotech™ Inc.